Literature DB >> 17371470

Coronary flow reserve is impaired in patients with adult growth hormone (GH) deficiency.

Huseyin Oflaz1, Fatma Sen, Ali Elitok, Arif Oguzhan Cimen, Imran Onur, Erdem Kasikcioglu, Semra Korkmaz, Mustafa Demirturk, Faruk Kutluturk, Burak Pamukcu, Nese Ozbey.   

Abstract

OBJECTIVE: Relationship between adult growth hormone deficiency (AGHD) and increased cardiovascular disease risk is very well known in hypopituitary patients treated with conventional hormone replacement therapy other than growth hormone (GH) administration. Endothelial dysfunction, an early and reversible event in pathogenesis of atherosclerosis, is associated with increased vascular smooth muscle tone, arterial stiffening and intima-media thickness (IMT). Coronary flow reserve (CFR) measurement by transthoracic Doppler echocardiography (TTDE) reflects coronary microvascular and endothelial functions, as a cheaper and an easy screening test. We have used TTDE to evaluate endothelial function and coronary microvascular function in AGHD.
DESIGN: Cross-sectional observational study. PATIENTS: A total of 10 GH-deficient adults on conventional replacement therapy other than GH (4 males, 6 females; mean age 37 +/- 11 years) and 15 healthy subjects (7 males, 8 females; mean age 41 +/- 11 years) were studied. Patients and controls were all nonsmokers, normotensive and nondiabetic. MEASUREMENTS: IGF-1, free T4, lipid profile, insulin, glucose, insulin resistance (IR), anthropometrical and physical parameters were recorded. CFR recordings and IMT measurements were performed using the Vivid 7 echocardiography device.
RESULTS: IMT were significantly higher in patients than controls (0.70 + 0.19 mm and 0.53 + 0.13 mm, respectively; P = 0.02). CFR was significantly lower in patients than in controls (1.96 +/- 0.35 and 2.62 +/- 0.45, respectively; P < 0.001). CFR was positively correlated with IGF-1 levels (r = 0.54, P = 0.005).
CONCLUSION: CFR is significantly lower in adults with GH deficiency than in controls. Direct correlation between CFR and IGF-1 concentrations suggests GH replacement could improve microvascular function and thereby could decrease cardiovascular morbidity and mortality in AGHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371470     DOI: 10.1111/j.1365-2265.2007.02767.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  Pharmacological Strategies to Retard Cardiovascular Aging.

Authors:  Irene Alfaras; Clara Di Germanio; Michel Bernier; Anna Csiszar; Zoltan Ungvari; Edward G Lakatta; Rafael de Cabo
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

2.  Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese Lewis dwarf rats: implications for vascular aging.

Authors:  Lora C Bailey-Downs; Danuta Sosnowska; Peter Toth; Matthew Mitschelen; Tripti Gautam; Jim C Henthorn; Praveen Ballabh; Akos Koller; Julie A Farley; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-11-10       Impact factor: 6.053

Review 3.  The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances.

Authors:  Zoltan Ungvari; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

4.  Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging.

Authors:  Lora C Bailey-Downs; Matthew Mitschelen; Danuta Sosnowska; Peter Toth; John T Pinto; Praveen Ballabh; M Noa Valcarcel-Ares; Julie Farley; Akos Koller; Jim C Henthorn; Caroline Bass; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-21       Impact factor: 6.053

5.  High prevalence of coronary calcifications and increased risk for coronary heart disease in adults with growth hormone deficiency.

Authors:  S Cannavò; F Marini; L Curtò; M L Torre; C de Gregorio; I Salamone; A Alibrandi; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2010-05-28       Impact factor: 4.256

6.  Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism.

Authors:  Huseyin Oflaz; Ramazan Kurt; Fatma Sen; Imran Onur; Arif Oguzhan Cimen; Ali Elitok; Kultigin Turkmen; Burak Pamukcu; Erdem Kasikcioglu; Zehra Bugra; Fehmi Mercanoglu; Nese Ozbey
Journal:  Endocrine       Date:  2008-01-26       Impact factor: 3.633

7.  Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice.

Authors:  Anna Csiszar; Nazar Labinskyy; Viviana Perez; Fabio A Recchia; Andrej Podlutsky; Partha Mukhopadhyay; Gyorgy Losonczy; Pal Pacher; Steven N Austad; Andrzej Bartke; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

8.  One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.

Authors:  Mara Boschetti; Sergio Agosti; Valeria Albanese; Laura Casalino; Claudia Teti; Gian Paolo Bezante; Claudio Brunelli; Manuela Albertelli; Diego Ferone
Journal:  Endocrine       Date:  2016-04-13       Impact factor: 3.633

9.  Adult growth hormone deficiency.

Authors:  Vishal Gupta
Journal:  Indian J Endocrinol Metab       Date:  2011-09

Review 10.  Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters.

Authors:  Carlo Dal Lin; Francesco Tona; Elena Osto
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.